Nasdaq

Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter into Third Amendment to the Accounts Receivable Purchase Agreement with Oasis Capital, LLC, Dated May 12, 2020

The Fourth Tranche Accounts Receivable has a gross value of $2,329,662.72, representing customer billings over a 24-day period "We are happy to enter into this additional amendment with Oasis. Based ...
Yahoo Finance

UK 2 Day Accounts Payable & Receivable Training Course | Gain Deep Expertise in Purchase Ledger and Customer Account Management

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Accounts Payable & Receivable Training Course (June 17-18, 2025)" training has been added to ResearchAndMarkets.com's offering. By mastering these ...
JD Supra

Working Capital and Accounts Receivable

When acquiring or selling a company, many nuances exist in various stages of the process, some of which are not readily apparent on their face. One of those nuances is the interplay between accounts ...
Seeking Alpha

VERSABANK ANNOUNCES THRIVE FINANCIAL AS NEW US RECEIVABLE PURCHASE PROGRAM PARTNER

LONDON, ON, Oct. 6, 2025 /PRNewswire/ - VersaBank (TSX: VBNK) (NASDAQ: VBNK), a North American leader in business-to-business digital banking, as well as technology solutions for cybersecurity, today ...
Investing

Caci International extends accounts receivable purchase agreement to 2026

CACI International Inc (NYSE:CACI) announced Monday that it has amended its Master Accounts Receivable Purchase Agreement. The amendment, executed on December 19 by CACI, Inc. – Federal, a wholly ...
TechRepublic

What Is the Difference between Accounts Receivable and Accounts Payable?

What Is the Difference between Accounts Receivable and Accounts Payable? Your email has been sent Accounts payable and receivable are required to ensure your cash flow and spending are appropriately ...
Nasdaq

Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter into a Second Amendment to the Accounts Receivable Purchase Agreement with Oasis Capital, LLC, Dated May 12, 2020

SAN FRANCISCO, CA / ACCESSWIRE / August 14, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Jaguar and its wholly owned subsidiary, Napo Pharmaceuticals, Inc., (collectively, the ...
Business Insider

Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter an Amendment to the Accounts Receivable Purchase Agreement with Oasis Capital, LLC, Dated May 12, 2020

Additional spring 2020 sales of Mytesi ® (beyond April 2020 sales) generate gross accounts receivable of $2,859,132 SAN FRANCISCO, CA / ACCESSWIRE / June 29, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX) ...